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↑What is “already known” in this topic: 
Diagnosis of PTE includes clinical and laboratory tests based 
on the available algorithms and criteria such as Wells’ criteria 
and revised Geneva score. CT angiography is overused in the 
patients with low and intermediate clinical probability.   
→What this article adds: 
In patients with low and intermediate clinical probability, other 
criteria such as PERC can be considered. If PERC is zero, no f
urther action is needed. If PERC criteria are above zero, a D-Di
mer is required. In case of positive D-Dimer, CT angiography  
is required to be done. 
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Abstract 
    Background: The aim of the present study was to evaluate the utilization and diagnostic yields of CT pulmonary angiography 
(CTPA)using the Revised Geneva score and Wells’ criteria, in patients with suspected pulmonary embolism (PE). 
   Methods: One hundred and twelve adult patients underwent CTPA for suspected PE were participated in this study. The outcome 
was positive or negative CTPA for PE. Revised Geneva and Wells’ scores were calculated. The relationship between the results ob-
tained from these two scores and the available risk factors were compared. 
Descriptive analysis such as frequency and mean as well as analytical statistics including chi-square were done. The data analysis was 
performed using SPSS (v. 22). 
   Results: In this study, according to the Wells’ criteria calculated for the patients, 33.9% of the patients had low clinical, 56.3% in-
termediate and 9.8% high clinical probability. Among the 11 high clinical patients, 9(81.8%) were CTPA positive. Based on the re-
vised Geneva score, 65 patients (58%) had low clinical, 36 (32.1%) intermediate and 11(9.8%) high clinical probability.  Among the 
11 high clinical patients, 8 were CTPA positive. Positive predictive value of the low clinical patients based on Wells’ criteria and the 
revised Geneva score was 18.4% and 30.8%, respectively. Also, positive predictive value for high clinical probability of Wells’ criteria 
and the revised Geneva score was 81.8% and 72.8% respectively.   
   Conclusion: Under/overuse of CTPA in diagnosing PTE is a common problem especially in university hospitals. It is possible to 
avoid unnecessary CTPA requests using scholarly investigations and more accurate clinical risk assessments.  
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Introduction 
Pulmonary thromboembolism (PTE) is a fairly common 
disease with nonspecific symptoms with potential high 
risk of mortality and morbidity (1). Diagnosis of PTE in-
cludes clinical and laboratory tests based on the available 
algorithms and criteria such as Wells’ criteria and revised 
Geneva score classifying patients to high, intermediate 
and low clinical probability. CT pulmonary angiography 
(CTPA) is the most sensitive and precise method in high 
probability cases (2, 3). Because of the non-specific symp-
toms of the disease, physicians are subject to diagnostic 
challenges, and there is also the possibility of CTPA re-
quest even in low clinical probability cases. According to 
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the related literature, the clinical competence of physi-
cians plays a key role in diagnosing patients properly and 
selecting diagnostic modalities. Therefore, in university 
hospitals, where the first clinical study is generally done 
by novice doctors, there is a possibility of improper deci-
sion making with regard to using CTPA, i.e. doing the 
procedure in unnecessary cases or, otherwise, failure to do 
it when it is actually required  (2-4). In this regard, 
Crichlow et.al. studied 152 patients with suspected PTE in 
the Hospital of the University of Pennsylvania, and con-
cluded that 9.2 % and 13.8% of the CTPA procedures 
could have been avoided by proper use of PERC and 
Wells/D-dimer, respectively (5). Molaee et al. in a cross-
sectional study carried out on 82 patients undergoing 
CTPA in a university hospital at Tehran University, Iran, 
reported that in patients with a likely clinical risk the 
prevalence of PTE was 62.2%. Of those subjects for 
whom CTPA was requested, the PTE of 54.8% was un-
likely according to modified Wells’ criteria.  Adherence 
rate to PTE diagnostic algorithm was only 43.9%. The 
researchers concluded that there were concerns regarding 
the excessive request for PTE work up by less-
experienced physicians (6). Choosing CTPA in unneces-
sary cases imposes considerable financial burdens on both 
the patients and the health providing center (directly or 
indirectly through increased hospitalization in the emer-
gency department). Moreover, it exposes the patients to 
iatrogenic effects, such as increasing risk of malignancy, 
contrast nephropathy, anaphylactic reactions and effects 
resulting from false positive cases. By the same token, not 
using CTPA in necessary cases increases mortality and 
morbidity risks; thus, further studies on the proper use of 
this valuable diagnostic method in university hospitals 
seems necessary (1, 2, 5, 6). To this aim, the present re-
search was a cross-sectional study on patients undergoing 
CTPA. Based on Wells’ criteria and the revised Geneva 
score, the patients were categorized into three groups of 
high, intermediate, and low probability. The relationship 
between the results obtained from these two tests and oth-
er risk factors (such as smoking, pregnancy, autoimmune 
diseases, HTN, OCP use, HRT, obesity, surgery history 
less than three months, stroke, and central vein catheteri-
zation) was studied to examine whether CTPA, as a diag-
nosis method, had been used properly. 
 
Methods 
This is a cross-sectional analytical descriptive study. 
The data were collected from medical records of 112 pa-
tients underwent pulmonary CT-Angiography as suspect-
ed PTE cases at Imam Khomeini Hospital in Ahvaz, 
southwest of Iran, from February, 2014 to March, 2015. 
This study was approved by the Ethics Committee of Ah-
vaz Jundishapur University of Medical Sciences. 
 CT-angiography interpretation was done by a pul-
monologist and a radiologist. The information was col-
lected using a checklist prepared based on Wells’ and re-
vised Geneva score. Wells’ criteria and the revised Gene-
va score were calculated for the patients without being 
aware of their CTPA results. According to Wells’ criteria, 
the patients were classified into less than 2 (low), 2-6 (in-
termediate) and above 6 (high), while based on the revised 
Geneva score, the patients were classified as 0-3 (low), 4-
10 (intermediate) and above 11 (high). Finally, the results 
obtained from Wells’ criteria and the revised Geneva 
score were compared with the risk factors available in the 
results of CT-ANGIO (positive vs. negative). The risk 
factors included: DVT symptoms, possible alternative 
diagnosis other than pulmonary embolism, immobility, 
heart rate above 100 beats per minute, history of surgery, 
DVT, PTE, cancer or hemoptysis. The study also exam-
ined PERC (Primary Emboli Rule out Criteria) which in-
cluded the following variables: age >50 years, 
HR>100/min, O2 sat on room>95%, prior history of ve-
nous thromboembolism, trauma or surgery within 4 
weeks, OCP, HRT and unilateral leg swelling.  
Pulmonary CT-angiography 
The CTPA of each patient was done by a fast 16-
detector computed tomography scanner with 4 detector 
arrays (Siemens Medical System). The CTPA was per-
formed while the patient lying in the supine position for 
less than a second. During the imaging procedure, the 
patients were asked to hold a single breath. Scan volume 
consisted the entire chest from the lung apex to its base in 
the cranio-caudal direction. The detector scan area was 
40mm. The slice thickness was 0.625 mm, and the tube 
current and voltage were 145ma and 120kv, respectively. 
Low osmolar nonionic contrast material (135-145ml) was 
injected through an arm vein during the procedure at a 
flow rate of 5ml/s. 
 
Statistical analysis 
To analyze the obtained data, descriptive statistics such 
as frequency, mean and standard deviation (SD), as well 
as analytical statistics including chi-square were 
calculated. A p-value less than 0.05 was considered statis-
tically significant. The data analysis was performed using 
SPSS (V. 22). 
Results 
In this study, the mean age of the participants was 
44.1±4 (14-91 years), and 76 (67.9%) participants were 
female of whom 31 (40.8%) were pregnant. Overally, 44 
(39%) patients were diagnosed as pulmonary embolism. 
Active DVT was positive for 20 (17.9%) patients with 
PTE, and past history of DVT was positive in 15 (13.4%) 
patients. In addition, no alternative diagnosis was likely 
other than pulmonary embolism in 59 (52.7%) patients. 
Five (4.5%) patients had malignancy, 67 (59.8%) immo-
bility, and 11 (9.8%) had hemoptysis. More details about 
the patients are shown in Table 1. 
According to Wells’ criteria calculated for the patients, 
38 (33.9%) patients had low clinical probability, 63 
(56.3%) with intermediate and 11 patients (9.8%) high 
clinical probability. Among the 11 high clinical patients, 9 
(81.8%) were CTPA positive (Table 2). Moreover, based 
on the revised Geneva score, 65 (58%) patients were in 
the low clinical category, 36 (32.1%) in the intermediate 
and 11 (9.8%) were in the high clinical category.  Among 
the 11 high clinical patients, 8 were CTPA positive (Table 
 









Positive and negative predictive values were calculated 
based on Wells’ criteria and the revised Geneva score. As 
Table 3 shows, positive predictive values of the patients 
with low clinical probability based on Wells’ criteria and 
revised Geneva score are 18.4% and 30.8%, respectively. 
In other words, if the result of Wells’ criteria for a patient 
is “low clinical”, the patient is 18.4% likely to be CTPA-
positive. 
Pulmonary embolism was also examined in pregnant 
women. The results obtained from Wells’ criteria revealed 
that 13 patients were in the low clinical category, 18 in 
moderate, and none was in the high clinical category. Of 
the pregnant women categorized as moderate clinical, 
only 4 were CTPA-positive (Table 4). The results of the 
revised Geneva score are shown in Table 4. 







Age>50 36/112 19(52.8%) 17(47.2%) 
Trauma 13/112 8 (61.5%) 5(38.5%) 
Hypertension 18/112 11(61.1%) 7(38.9%) 
OCP* or HRT** 8/112 3(37.5%) 5(62.5%) 
Pregnancy 31/112 4(12.9%) 27(87.1%) 
Smoking 20/112 10(50.0%) 10(50.0%) 
Operation in 3 month ago 34/112 14(41.2%) 20(58.8%) 
Stroke 4/112 4(100.0%) 0(0.0%) 
Autoimmune disease 6/112 3(50.0%) 3(50.0%) 
Catheter 0 0(0.0%) 0(0.0%) 
Deep vein thrombosis 20/112 12(60.0%) 8(40.0%) 
No  other  possible diagnosis 53/112 12(22.6%) 41(77.4%) 
HR>100 35/112 17(48.6%) 18(51.4%) 
O2sat>95% 78/112 21(26.0%) 57(74.0%) 
Immobility 67/112 20(29.8%) 47(70.2%) 
Past history of DVT or PTE 15/112 8(53.3%) 7(46.7%) 
Cancer 5/112 2(40.0%) 3(60.0%) 
Hemoptysis 11/112 7(63.6%) 4(36.4%) 
Leg edema 20/112 12(60.0%) 8(40.0%) 
Leg pain 19/112 11(57.9%) 8(42.1%) 
*   Oral contraceptive pill 
** Hormone  replace therapy 
 
Table 2. The relationship between Wells’ Criteria and the Revised Geneva Score, and the probability of PTE 
Wells’ Criteria CT Positive  
(N) 




Low 7 31 38 
Moderate 28 35 63 
High 9 2 11 
Total 44 68 112 
Revised Geneva Score    
Low 20 45 65 
Moderate 16 20 36 
High 8 3 11 
Total 44 68 112 
 
Table 3. Positive and negative predictive values for low and high clinical probabilities according to Wells’ Criteria and the Revised Geneva Score 












Low 7 31 38 Low 20 45 65 
High 9 2 11 High 8 3 11 
Total 16 33 49 Total 28 48 76 
Positive predictive value for low 18.4 % Positive predictive value for low 30.8% 
Positive predictive value for high 81.8 % Positive predictive value for high 72.7% 
Negative predictive value for low 81.6 % Negative predictive value for low 69.2% 
Negative predictive value for high 18.2 % Negative predictive value for high 27.3% 
 
Table 4. The relationship between the Wells’ Criteria s and Revised Geneva Score, and the probability of PTE in pregnant women 






Low 0 13 13 
Moderate 4 14 18 
High 0 0 0 
Total 4 27 31 
Revised Geneva Score    
Low 1 17 18 
Moderate 3 10 13 
High 0 0 0 
Total 4 27 31 
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PERC rule for patients with possible pulmonary embo-
lism was examined. The results revealed that 2, 32, 45, 28 
and 5 patients were scored as 1, 2, 3, 4, and 5 respectively. 
 
Discussion 
In general, our results show that 39% of patients under-
went CT angiography diagnosed as pulmonary embolism; 
this is consistent with other related studies. It does not 
seem that the usage of this diagnostic modality is more 
than other centers.  
Positive CT angiography test in patients with low, in-
termediate and high clinical probability was 18, 44, and 
82%, respectively, which was better than the results ob-
tained by Vongchaiudomchoke, (7) who reported positive 
pulmonary CT angiography for high, intermediate and low 
clinical patients as 59.3%, 39.3% and 7.95% respectively. 
Considering the diagnosis of embolism based on clinical 
and pulmonary angiography test, there is a study called 
PIOPED II (Prospective Investigation of Pulmonary Em-
bolism Diagnosis II) (8) in which the percentages for high, 
intermediate and low clinical patients were 92%, 96% and 
58%, resopectively. CT angiography was overused in pa-
tients with low and intermediate clinical probability. It 
seems that CT angiography request needs to be carried out 
based on clinical decisions made by a doctor taking into 
account various clinical criteria. It has been suggested that 
in patients with low clinical probability, the criteria need 
to be checked and other criteria such as PERC should be 
used. If PERC is zero, no further action is needed. How-
ever, if intermediate and/or low clinical probability plus 
PERC criteria are above zero, an age adjusted D-Dimer is 
required, and in case of its positivity, CT angiography is 
required to be done (9). Stojanovska et al. studied 602 
consecutive adult ED patients underwent CTPA for sus-
pected PE and reported that the use of PERC in the ED 
reduced the use of CTPA significantly and compared with 
Wells’ criteria missed fewer cases of PE, and this is a 
more efficient tool to make a decision (10). 
Among the 31 pregnant patients in our study, 4 were de-
tected to have pulmonary embolism and positive results 
were not significant compared to those reported by other 
centers. In another study conducted by Esther et al. (11) 
on 54 pregnant women undergoing CT angiography and 
V/Q scan, from 37 patients underwent CT angiography, 3 
were positive, which is almost similar to the results of our 
study.  
Wells’ criteria and other similar methods have been 
known to have low positive predictive value, making their 
results not valid and reliable for pregnant women (12). 
Since D-dimer levels are raised in normal pregnancy and 
early puerperium, present guidelines do not support D-
dimer measurement in the evaluation of suspected acute 
PTE in pregnancy (13,14). Also, there is up to a 10-time 
increase in VTE incidences in pregnant women compared 
to non-pregnant women. Side-effects of diagnostic proce-
dures such as breast cancer in mothers who undergo 
CTPA are more prevalent compared to those who undergo 
V/Q, and there is a higher possibility of childhood cancer 
in V/Q scan compared to CTPA. Therefore, careful deci-
sion-making should be made for pregnant women about 
doing this diagnostic procedure. In the absence of a defini-
tive diagnosis for dyspnea and the presence of clinical 
suspicion of pulmonary embolism, diagnosis procedure 
needs to be done with caution– for example bilateral lower 
limb Doppler ultrasound in pregnant women with suspect-
ed pulmonary embolism if they present with signs and 
symptoms of a DVT or using bismuth breast shield in 
CTPA which reduces radiation dosage up to 20-40%. If 
CXR is normal, applying perfusion scan is suggested, 
which reduces exposure to the fetus (15, 16, 17). 
Our study was a retrospective study based on our hospi-
tal records. One of its limitations was lack of follow-up in 
patients with negative CT pulmonary angiography, and 
thus we are not sure about the occurrence of pulmonary 
emboli and DVT after discharge. However, there was no 
other hospital in the province other than ours to admit 
patients with pulmonary problems and pulmonary embo-
lism, and we believe in case of vascular problems the pa-
tients themselves present to our hospital, or the hospital 
they initially go, refers them to our hospital which is the 
only pulmonary center in the province. The second limita-
tion of the study was lack of D-Dimer test for all patients 
with intermediate and low clinical suspicion. Some of the 
patients were hospitalized, and CTPA was carried out for 
them after clinical suspicion. However, we suggest age 
adjusted D-Dimer Eliza in patients with intermediate and 
low clinical suspicion if their PERC is positive. None of 
the studied patients underwent CT pulmonary angi-




In conclusion, underuse and overuse of CTPA in diag-
nosing PTE is a common problem especially in university 
hospitals. It is possible to avoid unnecessary CTPA re-
quests by more adherence to recommendations of studies 
and following more accurate clinical risk assessment done 
by experienced clinicians.  
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